BDBM102340 US10562854, No. C33::US8536181, C33::US9278930, C33
SMILES: CSCCNCc1ccn(Cc2ccccc2)c(=O)c1O
InChI Key: InChIKey=QGEIIBDJASWVRH-UHFFFAOYSA-N
Data: 8 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Egl nine homolog 1 (Homo sapiens (Human)) | BDBM102340 (US10562854, No. C33 | US8536181, C33 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description EGLN enzyme activity assay is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-TOF MS. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM102340 (US10562854, No. C33 | US8536181, C33 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description ELISA assay using VEGF. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 (Homo sapiens (Human)) | BDBM102340 (US10562854, No. C33 | US8536181, C33 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.60E+4 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-T... | US Patent US8778412 (2014) BindingDB Entry DOI: 10.7270/Q2WS8RZ9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM102340 (US10562854, No. C33 | US8536181, C33 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO THERAPEUTICS, INC. US Patent | Assay Description VEGF: HEK293 cells are seeded in 96-well poly-lysine coated plates at 20,000 cells per well in DMEM (10% FBS, 1% NEAA, 0.1% glutamine). Following ove... | US Patent US10562854 (2020) BindingDB Entry DOI: 10.7270/Q2668GK0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hypoxia-inducible factor prolyl hydroxylase 2 (HIFPH2) (Homo sapiens (Human)) | BDBM102340 (US10562854, No. C33 | US8536181, C33 | US9278930, ...) | PDB GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.60E+4 | n/a | n/a | n/a | n/a | 7.5 | 25 |
AERPIO THERAPEUTICS, INC. US Patent | Assay Description The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-T... | US Patent US9278930 (2016) BindingDB Entry DOI: 10.7270/Q24J0CZG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM102340 (US10562854, No. C33 | US8536181, C33 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO THERAPEUTICS, INC. US Patent | Assay Description HEK293 cells are seeded in 96-well poly-lysine coated plates at 20,000 cells per well in DMEM (10% FBS, 1% NEAA, 0.1% glutamine). Following overnight... | US Patent US9278930 (2016) BindingDB Entry DOI: 10.7270/Q24J0CZG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 (Homo sapiens (Human)) | BDBM102340 (US10562854, No. C33 | US8536181, C33 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AERPIO THERAPEUTICS, INC. US Patent | Assay Description The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-T... | US Patent US10562854 (2020) BindingDB Entry DOI: 10.7270/Q2668GK0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM102340 (US10562854, No. C33 | US8536181, C33 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description HEK293 cells are seeded in 96-well poly-lysine coated plates at 20,000 cells per well in DMEM (10% FBS, 1% NEAA, 0.1% glutamine). Following overnight... | US Patent US8778412 (2014) BindingDB Entry DOI: 10.7270/Q2WS8RZ9 | |||||||||||
More data for this Ligand-Target Pair |